Peter H. Wiernik, MD
Current Position: Director, Cancer Research Foundation of New York
Education: BS (1961), MD (1965) University of Virginia; medical internship, Cleveland Metropolitan General Hospital (1966); medical residency (1970-1), Johns Hopkins Hospital; Medical oncology/hematology fellowship, National Cancer Institute (1966-69).
Clinical Interest: Cancer research and treatment
Research Interest: Clinical trials and clinical pharmacology
Awards and Honors: Doctor honoris causa, University of the Republic, Uruguay (1982); Janeway Lecturer (1996) and past president (1993-4), American Radium Society; Gold Medal, First Polish Oncology Conference (2002); Elected to membership, American Society of Clinical Investigation (1978) and Fellowship, AAAS (1977), ACP (1974), ACCP (1974), ASCO (2008); Celgene Career Achievement Award (2009); Walter Reed Distinguished Career Achievement Award, University of Virginia School of Medicine (2016); Marquis Distinguished Career Award (2017); Nathaniel T. Kwit Memorial Distinguished Service Award from the American College of Clinical Pharmacology (2019).
Other: Professor of Medicine and Radiation Oncology, Albert Einstein College of Medicine (1982-98) and New York Medical College (1998-2009); Director, Baltimore Cancer Research Center of the NCI (1976-82); Associate Director for Clinical Research, Albert Einstein Cancer Center (1982-98); Regent of the American College of Clinical Pharmacology (2012-17); Chair, Adult Leukemia Committee, CALGB (1976-82) and ECOG (1989-93); Chair, Eastern Division, AFMR (2014-15); Author of more than 750 peer reviewed papers and Senior Editor of 6 editions of Neoplastic Diseases of the Blood (2001-18).
Current AFMR position: Councilor-at-Large
Term: 5/01/21- 04/30/24